NLS
January 15, 2017
[aas_zone zone_id=”7913″]
Published: January 15, 2017
Top stories
Biotech Business – August 21, 2026
The company has announced confidential submission of draft registration statement to the SEC to allow for a potential listing of ADSs in the United States.
MedTech Business – August 21, 2026
The FDA has granted Premarket Approval (PMA) for RefluxStop, the company’s implant-based treatment for gastroesophageal reflux disease (GERD).
Agreement – August 21, 2026
Swedish biotech company Akiram Therapeutics has signed an agreement with ITM Isotope Technologies Munich to supply non-carrier-added lutetium-177 for the clinical development of AKIR001.
Financing – August 21, 2026
Eyedentity, a company in the Karolinska Institutet Innovation Incubator, has closed an oversubscribed investment round led by Norrsken Launcher.
Related posts
Advertising free banner - January 15, 2017
[aas_zone zone_id=”8010″]
[aas_zone zone_id=”7909″]
[aas_zone zone_id=”7910″]
[aas_zone zone_id=”7915″]
This site uses cookies
Read more about our privacy policy
The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.
The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.
The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.